/PRNewswire/ -- The "Clean Energy Jobs and American Power Act" introduced by Senators Barbara Boxer (D-CA) and John Kerry (D-MA) favors corporate interests over our national interest, says the Free Enterprise Project of the National Center for Public Policy Research. The bill calls for a 20% reduction in emissions, exceeding the 17% target in the House Waxman-Markey legislation passed in May.
Boxer-Kerry lacks many important details, including a disclosure of which industries will benefit from free emissions credits.
"In the rush to legislate, the Boxer-Kerry bill is silent on key elements, such as how the government will hand out free emissions allowances that are worth billions of dollars. With that amount of money left on the table it opens the door for a behind-the-scenes lobbying fest that will reward well connected companies while looting taxpayers," said Tom Borelli, PhD, director of the Free Enterprise Project.
Waxman-Markey awards most of the estimated $777.6 billion of free allowances to industry between 2012-2020. Utilities were the biggest winner in the "House bill lottery," receiving 35% of allowances.
President Obama originally wanted to auction all the emission credits with the revenue going to reduce the budget deficit.
In addition to the allowance windfall, a few select companies will benefit from specific provisions. Caterpillar would gain from sales of its newly-developed hybrid bulldozer, because the bill empowers the EPA to issue new emissions standards for "new heavy-duty vehicles and engines and for nonroad vehicles and engines."
The Caterpillar hybrid bulldozer is priced about $100,000 more than conventional bulldozers -- an added cost that will be passed on to construction projects.
According to the Free Enterprise Project, the Boxer gift to Caterpillar may be a reward for CEO Jim Owens. Under Owens, Caterpillar is a member of the U.S. Climate Action Partnership (USCAP) -- a coalition of corporate and environmental special interest groups lobbying for cap-and-trade. Owens is a member of President Obama's Economic Recovery Advisory Board.
"Owens is putting his personal short-term interest over our national interest. He has previously acknowledged that cap-and-trade can harm the competitiveness of our manufacturing industries, yet he remains a member of USCAP," added Borelli. "Owens' thirty pieces of silver is a hybrid bulldozer."
"It's clear the only winners with cap-and-trade will be the lobbyists, CEOs and their environmental allies. The bill represents a huge transfer of wealth in the amount of hundreds of billions of dollars to industry. While the Washington elite benefit, the rest of America will end up paying the cost through higher energy prices, slower economic growth and sending jobs overseas," said Borelli.
-----
www.politicalpotluck.com
Political News You Can Use
Showing posts with label lobbyist. Show all posts
Showing posts with label lobbyist. Show all posts
Friday, October 2, 2009
Tuesday, August 11, 2009
Guess who’s funding ObamaCare advocates?
Facebook finding:
Greg Sargent notes that a familiar face will start showering cash on organizations trying to build support for ObamaCare. George Soros, who once pledged his entire fortune in an unsuccessful effort to unseat George Bush, has pledged another $5 million to overcome popular opposition to the government takeover of the health-care industry. Sargent rightly notes that this will become a flashpoint for both sides of the divide:
In another sign of the urgency gripping the pro-health care reform camp, billionaire George Soros has pledged to sink $5 million into the fight, the group getting the money confirmed.
Soros — whose operation carefully guards the privacy of such donations — made the pledge to Health Care For America Now, the leading coalition of pro-reform groups, unions and providers, HCAN chief Richard Kirsch confirmed in an email that was forwarded to me. …
The Soros pledge is noteworthy, because both sides will seize on it. The right will say it shows the real astroturfing is coming from the pro-reform side — billionaire bogeyman Soros is bankrolling this fight!
The left will cite the donation to demand that HCAN show real results. Some on the left, such as blogger Jane Hamsher, have been asking why heavily-bankrolled HCAN hasn’t been able to secure more commitments from Dem members of Congress to stand firm behind a public option.
However, that group may run afoul of Rahm Emanuel and the White House. Emanuel has demanded that HCAN and other advocacy groups focus their sights on Republicans and stop attacking vulnerable Democrats — which, in this case, would be those who have shown great reluctance to get on board with ObamaCare. If HCAN takes Emanuel’s advice, it’s hard to see what they’ll use the money to do, other than buy advertising that strictly focuses on the issue. That issue hasn’t played well thus far, and $5 million of advertising won’t make a dent in the opposition.
That’s where the pharmaceutical industry’s cash will come in handy:
The drug industry has authorized its lobbyists to spend as much as $150 million on television commercials supporting President Obama’s health care overhaul, beginning over the August Congressional recess, people briefed on the plans said Saturday.
The unusually large scale of the industry’s commitment to the cause helps explain some of a contentious back-and-forth playing out in recent days between the odd-couple allies over a deal that the White House struck with the industry in June to secure its support. The terms of the deal were not fully disclosed. Both sides had announced that the drug industry would contribute $80 billion over 10 years to the cost of the health care overhaul without spelling out the details.
With House Democrats moving to extract more than that just as the drug makers finalized their advertising plans, the industry lobbyists pressed the Obama administration for public reassurances that it had agreed to cap the industry’s additional costs at $80 billion. The White House, meanwhile, has struggled to mollify its most pivotal health industry ally without alienating Congressional Democrats who want to demand far more of the drug makers. White House officials could not immediately be reached for comment.
To give this some perspective, it helps to recall that John McCain spent $126 million on advertising for the entire general election campaign in 2008. Why have the pharmaceuticals gone for ObamaCare in a big way? Obama promised not to use Medicare’s market advantage to drive down prices any more than the $80 billion already pledged by the industry. That’s basically price-fixing of a kind that the Federal Trade Commission would investigate if it involved a private-sector insurance giant.
Remind me again which side is Astroturfing and getting big, powerful firms funding their operation, and which one represents the actual sense of Americans on government-controlled health care.
From:
from http://www.facebook.com/l/;Hotair.com
via Facebook group: Expose Soros & Other Far-Left Financiers
Greg Sargent notes that a familiar face will start showering cash on organizations trying to build support for ObamaCare. George Soros, who once pledged his entire fortune in an unsuccessful effort to unseat George Bush, has pledged another $5 million to overcome popular opposition to the government takeover of the health-care industry. Sargent rightly notes that this will become a flashpoint for both sides of the divide:
In another sign of the urgency gripping the pro-health care reform camp, billionaire George Soros has pledged to sink $5 million into the fight, the group getting the money confirmed.
Soros — whose operation carefully guards the privacy of such donations — made the pledge to Health Care For America Now, the leading coalition of pro-reform groups, unions and providers, HCAN chief Richard Kirsch confirmed in an email that was forwarded to me. …
The Soros pledge is noteworthy, because both sides will seize on it. The right will say it shows the real astroturfing is coming from the pro-reform side — billionaire bogeyman Soros is bankrolling this fight!
The left will cite the donation to demand that HCAN show real results. Some on the left, such as blogger Jane Hamsher, have been asking why heavily-bankrolled HCAN hasn’t been able to secure more commitments from Dem members of Congress to stand firm behind a public option.
However, that group may run afoul of Rahm Emanuel and the White House. Emanuel has demanded that HCAN and other advocacy groups focus their sights on Republicans and stop attacking vulnerable Democrats — which, in this case, would be those who have shown great reluctance to get on board with ObamaCare. If HCAN takes Emanuel’s advice, it’s hard to see what they’ll use the money to do, other than buy advertising that strictly focuses on the issue. That issue hasn’t played well thus far, and $5 million of advertising won’t make a dent in the opposition.
That’s where the pharmaceutical industry’s cash will come in handy:
The drug industry has authorized its lobbyists to spend as much as $150 million on television commercials supporting President Obama’s health care overhaul, beginning over the August Congressional recess, people briefed on the plans said Saturday.
The unusually large scale of the industry’s commitment to the cause helps explain some of a contentious back-and-forth playing out in recent days between the odd-couple allies over a deal that the White House struck with the industry in June to secure its support. The terms of the deal were not fully disclosed. Both sides had announced that the drug industry would contribute $80 billion over 10 years to the cost of the health care overhaul without spelling out the details.
With House Democrats moving to extract more than that just as the drug makers finalized their advertising plans, the industry lobbyists pressed the Obama administration for public reassurances that it had agreed to cap the industry’s additional costs at $80 billion. The White House, meanwhile, has struggled to mollify its most pivotal health industry ally without alienating Congressional Democrats who want to demand far more of the drug makers. White House officials could not immediately be reached for comment.
To give this some perspective, it helps to recall that John McCain spent $126 million on advertising for the entire general election campaign in 2008. Why have the pharmaceuticals gone for ObamaCare in a big way? Obama promised not to use Medicare’s market advantage to drive down prices any more than the $80 billion already pledged by the industry. That’s basically price-fixing of a kind that the Federal Trade Commission would investigate if it involved a private-sector insurance giant.
Remind me again which side is Astroturfing and getting big, powerful firms funding their operation, and which one represents the actual sense of Americans on government-controlled health care.
From:
from http://www.facebook.com/l/;Hotair.com
via Facebook group: Expose Soros & Other Far-Left Financiers
Subscribe to:
Posts (Atom)